Biomedica-Anpartsselskab: Financial statements 2019
CVR: 15234474
Biomedica-Anpartsselskab (CVR 15234474) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 2,725,000 and a net result of DKK 1,372,614 compared with DKK 37,750 the year before. That is an increase of 354.2% compared with the year before. The profit margin was 50.4%. Equity amounted to DKK 106,906. The solvency ratio was 4.7%.
- Revenue
- 2,725,000 kr.
- Gross Profit
- 1,713,797 kr.
- Profit/Loss
- 1,372,614 kr.
- Equity
- 106,906 kr.
- Total Assets
- 2,267,199 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 2.7 mio. | 1.7 mio. | 1.4 mio. | 107 t. | - |
| 2018 | 600 t. | 38 t. | 38 t. | -1.3 mio. | - |
| 2017 | 0 | -4 t. | -4 t. | -1.3 mio. | - |
| 2016 | 0 | -4 t. | -4 t. | -1.3 mio. | - |
| 2015 | 0 | -3 t. | -3 t. | -1.3 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
Biomedica-Anpartsselskab has published its annual report for 2018. Revenue came to DKK 600,000, and the net result was DKK 37,750.
About Biomedica-Anpartsselskab
Biomedica-Anpartsselskab is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 1991. The company is registered under the industry Vikarbureauers aktiviteter og anden personaleformidling. The management consists of Lars Anders Baumbach. The company is owned by Lars Anders Baumbach. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -28,050 compared with DKK 307,277 the year before. Equity amounted to DKK 2,702,360.
